- Original Article
-
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
-
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
-
Clin Mol Hepatol. 2020;26(3):352-363. Published online May 28, 2020
-
-
- 3
-
Efficacy of 48-week clevudine therapy for chronic hepatitis B
-
Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D.,
Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D.,
Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.
-
Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009
-
-
|